Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDeciphera Pharma Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Deciphera Pharma Earnings Date And Information
Deciphera Pharma last posted its earnings results on Friday, May 10th, 2024. The company reported $-0.52 earnings per share for the quarter, topping analysts' consensus estimates of $-0.55 by $0.03. The company had revenue of 45.00 M for the quarter and had revenue of 163.36 M for the year. Deciphera Pharma has generated $-2 earnings per share over the last year ($-2.29 diluted earnings per share) and currently has a price-to-earnings ratio of -11.17. Deciphera Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Deciphera Pharma Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/10/2024 | Q1 2024 | -$0.55 | -$0.52 | 0.03 | $45.00 M | $45.00 M |
| 02/07/2024 | Q4 2023 | N/A | -$0.54 | N/A | $45.93 M | $48.29 M |
| 10/30/2023 | Q3 2023 | -$0.60 | -$0.58 | 0.02 | $39.45 M | $43.31 M |
| 08/09/2023 | Q2 2023 | -$0.62 | -$0.57 | 0.05 | $36.09 M | $38.30 M |
| 05/03/2023 | Q1 2023 | -$0.60 | -$0.60 | 0 | $35.69 M | $33.45 M |
| 02/07/2023 | Q4 2022 | -$0.57 | -$0.60 | -0.03 | $35.97 M | $36.35 M |
| 11/03/2022 | Q3 2022 | -$0.57 | -$0.50 | 0.07 | $33.08 M | $35.97 M |
| 08/04/2022 | Q2 2022 | -$0.65 | -$0.58 | 0.07 | $30.56 M | $32.49 M |
| 05/04/2022 | Q1 2022 | -$0.84 | -$0.79 | 0.05 | $26.88 M | $29.22 M |
| 02/08/2022 | Q4 2021 | -$1.49 | -$1.51 | -0.02 | $23.41 M | $24.20 M |
| 11/02/2021 | Q3 2021 | -$1.29 | -$1.37 | -0.08 | $23.47 M | $23.22 M |
| 08/03/2021 | Q2 2021 | -$1.15 | -$1.21 | -0.06 | $21.93 M | $23.57 M |
| 05/04/2021 | Q1 2021 | -$1.08 | -$1.06 | 0.02 | $22.46 M | $25.16 M |
| 02/09/2021 | Q4 2020 | -$1.16 | -$1.11 | 0.05 | $18.65 M | $19.49 M |
| 11/05/2020 | Q3 2020 | -$1.32 | -$1.13 | 0.19 | $6.71 M | $15.45 M |
| 08/04/2020 | Q2 2020 | -$1.34 | -$1.20 | 0.14 | $877.78 K | $7.09 M |
| 05/05/2020 | Q1 2020 | -$1.28 | -$1.36 | -0.08 | $56.99 K | $62.00 K |
| 03/09/2020 | Q4 2019 | -$1.13 | -$1.31 | -0.18 | $1.25 M | $0 |
| 11/04/2019 | Q3 2019 | -$1.19 | -$1.28 | -0.09 | $454.55 K | $0 |
| 08/02/2019 | Q2 2019 | -$1.06 | -$0.56 | 0.5 | $2.00 M | $25.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Deciphera Pharma Earnings: FAQ's
In the previous quarter, Deciphera Pharma (:DCPH) reported $-0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.55 by $0.03.
The conference call for Deciphera Pharma's latest earnings report can be listened to online.
The conference call transcript for Deciphera Pharma's latest earnings report can be read online.
Deciphera Pharma (:DCPH) has a recorded annual revenue of $163.36 M.
Deciphera Pharma (:DCPH) has a recorded net income of $-194,942,000.Deciphera Pharma has generated $-2.29 earnings per share over the last four quarters.
Deciphera Pharma (:DCPH) has a price-to-earnings ratio of -11.17 and price/earnings-to-growth ratio is -3.93.